A detailed history of Stonepine Capital Management, LLC transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 110,000 shares of ETON stock, worth $941,600. This represents 0.33% of its overall portfolio holdings.

Number of Shares
110,000
Previous 110,000 -0.0%
Holding current value
$941,600
Previous $362 Million -0.0%
% of portfolio
0.33%
Previous 0.33%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$3.06 - $3.75 $336,600 - $412,500
110,000 New
110,000 $362 Million

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $217M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.